Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : JAG201
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Deerfield Management
Deal Size : Undisclosed
Deal Type : Financing
Advanced Medicine Partners Launches for Manufacturing and Testing Advanced Medicines
Details : Proceeds will support CMC efforts for JAG201, a gene therapy in preclinical development for autism spectrum disorder and other neurodevelopmental disorders.
Product Name : JAG201
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 16, 2024
Lead Product(s) : JAG201
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Deerfield Management
Deal Size : Undisclosed
Deal Type : Financing